Error in the Text

June 1, 2026
0 min

Jama Internal Medicine

Overview

This correction notice addresses an error in the reporting of baseline QTc intervals in the article on rapid methadone titration for opioid withdrawal management. The corrected QTc threshold is now established as greater than 500 ms, aligning with current clinical guidelines.

Background

QTc interval prolongation is a critical concern in the management of patients undergoing opioid withdrawal, particularly with methadone. Accurate reporting of QTc intervals is essential for assessing the risk of torsades de pointes (TdP), a potentially life-threatening arrhythmia. This correction highlights the importance of adhering to established thresholds in clinical practice to ensure patient safety.

Data Highlights

No numerical data was provided in the correction notice.

Key Findings

The baseline QTc interval threshold for methadone titration is corrected to greater than 500 ms.
QTc prolongation is associated with an increased risk of torsades de pointes (TdP).
Current guidelines emphasize the need for ECG monitoring in patients receiving methadone.
Rapid methadone titration protocols include specific criteria for monitoring QTc intervals.
Drug interactions can exacerbate QTc prolongation, necessitating careful medication management.

Clinical Implications

Clinicians should ensure accurate QTc interval reporting to mitigate the risk of TdP in patients undergoing methadone treatment. Adhering to the corrected threshold of greater than 500 ms is crucial for safe prescribing practices.

Conclusion

This correction serves as a reminder of the importance of precise clinical data in opioid withdrawal management. Ongoing vigilance in monitoring QTc intervals will enhance patient safety in this vulnerable population.